Recovery & Healing

Cartalax

Cartalax (Ala-Glu-Asp)

Khavinson tripeptide for cartilage and connective tissue

Cartalax is a synthetic tripeptide bioregulator from the Khavinson group, targeting cartilage and connective tissue health. It is used in Russian medicine for joint-related conditions.

Car
💉

Admin routes

Oral (capsule)

🔬

Popularity

Niche

✅

Side effects

Generally mild

🏪

AU vendors

0 rated

✓Key benefits

1Supports cartilage and connective tissue health (Russian data)
2Oral administration for convenience
3Used for osteoarthritis and joint degeneration in Russian medicine

📈What to expect

1
Day 10-20

Some users report reduced joint stiffness after a course

2
Post-cycle

Benefits reported to persist for 3-6 months

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Joint support (Russian protocol)

Dose

10 mg (1-2 capsules)

Frequency

1-2 times daily

Duration

10-20 day courses, 2-3 times per year

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Research status|Used in Russian clinical practice; limited Western peer review

Overview

Cartalax is a tripeptide (Ala-Glu-Asp) developed as part of the Khavinson peptide bioregulator program in Saint Petersburg. It is designed to support cartilage and connective tissue by restoring protein synthesis in chondrocytes (cartilage cells). In Russian clinical practice, it is used for osteoarthritis, joint degeneration, and age-related decline in cartilage quality. Like other Khavinson bioregulators, it is taken as an oral capsule in short courses repeated throughout the year.

⚙️How it works

Proposed to interact with DNA regulatory regions in chondrocytes, influencing gene expression related to collagen synthesis, proteoglycan production, and cartilage matrix maintenance. Khavinson's group has published data suggesting that short peptides can penetrate cell nuclei and bind to specific DNA sequences, but this mechanism remains outside mainstream pharmacological consensus.

⚡Side effects

Generally well-tolerated
mildRare

📅Research history

2000s

Cartalax developed at the Saint Petersburg Institute of Bioregulation

References

  1. [1]Khavinson VK, et al. 'Short peptides stimulate cell regeneration.' Advances in Gerontology, 2011.

Frequently asked questions

Related peptides

BPC-157

Recovery & Healing

The recovery peptide backed by 30+ years of research

6 rated vendors

TB-500

Recovery & Healing

Systemic tissue repair - from tendons to cardiac muscle

6 rated vendors

Bronchogen

Immune Support

Khavinson's four-amino-acid lung bioregulator

0 rated vendors

Thymalin

Immune Support

The thymus bioregulator peptide used clinically in Russia since 1982

0 rated vendors

Community experiences

Share your experience with Cartalax. Effects, side effects, protocol details - help others make informed decisions.

Write a review

Rating:

No community reviews yet. Be the first to share your experience with Cartalax.

Need to calculate your dose?

Use our free reconstitution calculator to work out syringe units for Cartalax.

Open Calculator

Found this useful?

Share this guide

Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.